Idioma:

Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice

Leesombun, Arpron ; Nihei, Coh-ichi ; Kondoh, Daisuke ; Nishikawa, Yoshifumi

Parasitology research (1987), 2022-01, Vol.121 (1), p.413-422 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por

Enviar para

Título:
Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice
Autor: Leesombun, Arpron ; Nihei, Coh-ichi ; Kondoh, Daisuke ; Nishikawa, Yoshifumi
Assuntos: Analysis ; Animals ; Antibiotics ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Chemotherapy ; Clindamycin ; Electron microscopy ; Growth ; Health aspects ; HIV ; Human immunodeficiency virus ; Immunology ; Ionophores ; Medical Microbiology ; Medical research ; Medicine, Experimental ; Membrane potential ; Mice ; Microbiology ; Mitochondria ; Monensin ; Nishikawa, Yoshifumi ; Opportunist infection ; Parasites ; Protozoa ; Pyrans ; Pyrimethamine ; Reactive oxygen species ; Spiramycin ; Tachyzoites ; Toxoplasma ; Toxoplasma gondii ; Toxoplasmosis ; Treatment and Prophylaxis - Original Paper
É parte de: Parasitology research (1987), 2022-01, Vol.121 (1), p.413-422
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: The natural polyether ionophore antibiotics may be important chemotherapeutic agents. Among them, kijimicin represents an important type of ionophore compound because it inhibits Eimeria tenella and human immunodeficiency virus. The ionophore monensin displays potent activities against several coccidian parasites including the opportunistic pathogen of humans, Toxoplasma gondii . At first, we evaluated the anti- Toxoplasma activity of kijimicin, monensin as a reference control, and anti- Toxoplasma drugs such as clindamycin, in vitro. The half inhibitory concentrations (IC 50 ) for the anti- Toxoplasma activities of kijimicin, monensin, and clindamycin were 45.6 ± 2.4 nM, 1.3 ± 1.8 nM, and 238.5 ± 1.8 nM, respectively. Morphological analyses by electron microscopy revealed cellular swelling and multiple intracellular vacuole-like structures in the T. gondii tachyzoites after treatment with kijimicin and monensin. Kijimicin and monensin also inhibited the invasion of extracellular parasites (IC 50 = 216.6 ± 1.9 pM and 531.1 ± 1.9 pM, respectively). Importantly, kijimicin treatment resulted in decreased mitochondrial membrane potential and generation of reactive oxygen species in T. gondii as monensin did. Furthermore, mice treated with kijimicin at 10 mg/kg/day and 3 mg/kg/day showed 91.7% and 66.7% survival rates, respectively, 30 days after infection with T. gondii . The control mice all died within 18 days of infection. The present study shows that kijimicin inhibits T. gondii growth and changes the ultrastruct of the parasites. This finding may lead to validation of kijimicin as new drug to control T. gondii growth.
Editor: Berlin/Heidelberg: Springer Berlin Heidelberg
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 10 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice

Leesombun, Arpron ; Nihei, Coh-ichi ; Kondoh, Daisuke ; Nishikawa, Yoshifumi

Berlin/Heidelberg: Springer Berlin Heidelberg

Buscando em bases de dados remotas. Favor aguardar.